EMD-16375

Single-particle
2.68 Å
EMD-16375
3D View Gallery
Deposition: 19/12/2022
Map released: 19/06/2024
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-16375
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8c0y summary report (pdf.gz) Map and 8c0y FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody

EMD-16375

Single-particle
2.68 Å
EMD-16375
3D View Gallery
Deposition: 19/12/2022
Map released: 19/06/2024
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens, Enterobacteria phage T4
Sample: SARS-CoV2 Omicron BA.1 Spike in complex with CAB-A17 antibody
Fitted models: 8c0y

Deposition Authors: Das H, Hallberg BM
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies.
Sheward DJ, Pushparaj P, Das H, Greaney AJ, Kim C, Kim S, Hanke L, Hyllner E, Dyrdak R, Lee J, Dopico XC, Dosenovic P, Peacock TP , McInerney GM, Albert J, Corcoran M, Bloom JD, Murrell B, Karlsson Hedestam GB, Hallberg BM
(2024) Cell Rep Med , 101577 - 101577
PUBMED: 38761799
DOI: doi:10.1016/j.xcrm.2024.101577
ISSN: 2666-3791